Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Katharina Manassis. (2007) When attention-deficit/hyperactivity disorder co-occurs with anxiety disorders: effects on treatment. Expert Review of Neurotherapeutics 7:8, pages 981-988.
Read now
Read now
Articles from other publishers (28)
Miranda Stiernborg, JW Debelius, Liu L. Yang, Elin Skott, Vincent Millischer, MaiBritt Giacobini, Philippe A. Melas, Fredrik Boulund & Catharina Lavebratt. (2023) Bacterial gut microbiome differences in adults with ADHD and in children with ADHD on psychostimulant medication. Brain, Behavior, and Immunity 110, pages 310-321.
Crossref
Crossref
Hueng-Chuen Fan, Kuo-Liang Chiang, Kuang-Hsi Chang, Chuan-Mu Chen & Jeng-Dau Tsai. (2023) Epilepsy and Attention Deficit Hyperactivity Disorder: Connection, Chance, and Challenges. International Journal of Molecular Sciences 24:6, pages 5270.
Crossref
Crossref
Daniela Vázquez-González, Sonia Carreón-Trujillo, Lourdes Alvarez-Arellano, Daniela Melissa Abarca-Merlin, Pablo Domínguez-López, Marcela Salazar-García & Juan Carlos Corona. 2023. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders. Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders
327
356
.
Alok Singh, Mahesh Kumar Balasundaram & Abhishek Singh. (2022) Viloxazine for Attention-Deficit Hyperactivity Disorder: A Systematic Review and Meta-analysis of Randomized Clinical Trials. Journal of Central Nervous System Disease 14, pages 117957352210925.
Crossref
Crossref
Julie Sarno Owens, Chelsea L. Hustus, Elise L. Everly, Steven W. Evans & Samantha M. Margherio. 2022. Comprehensive Clinical Psychology. Comprehensive Clinical Psychology
395
411
.
Ying Zhang, Xiu Xu & Kaifeng Zhang. (2021) Atomoxetine-Associated Eyebrow Alopecia in a Girl With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 41:5, pages 605-606.
Crossref
Crossref
Mojtaba Khaksarian, Nazanin Ahangari, Abbas Masjedi-Arani, Iman Mirr, Hassan Jafari, Saeed Kordian, Roghieh Nooripour & Saba Hassanvandi. (2021) A Comparison of Methylphenidate (MPH) and Combined Methylphenidate with Crocus sativus (Saffron) in the Treatment of Children and Adolescents with ADHD: A Randomized, Double-blind, Parallel-Group, Clinical Trial. Iranian Journal of Psychiatry and Behavioral Sciences 15:3.
Crossref
Crossref
Eleonora Rosi, Silvia Grazioli, Filippo Maria Villa, Maddalena Mauri, Erica Gazzola, Marco Pozzi, Massimo Molteni & Maria Nobile. (2020) Use of Non-Pharmacological Supplementations in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Critical Review. Nutrients 12:6, pages 1573.
Crossref
Crossref
Rima Kaddurah-Daouk, Thomas Hankemeier, Elizabeth H. Scholl, Rebecca Baillie, Amy Harms, Claus Stage, Kim P. Dalhoff, Gesche Jűrgens, Olivier Taboureau, Grace S. Nzabonimpa, Alison A. Motsinger-Reif, Ragnar Thomsen, Kristian Linnet & Henrik B. Rasmussen. (2018) Pharmacometabolomics Informs About Pharmacokinetic Profile of Methylphenidate. CPT: Pharmacometrics & Systems Pharmacology 7:8, pages 525-533.
Crossref
Crossref
Elaheh SalardiniAtefeh ZeinoddiniAsghar KohiMohammad-Reza MohammadiPayam MohammadinejadMohammad KhiabanyMona ShahriariShahin Akhondzadeh. (2016) Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial. Journal of Child and Adolescent Psychopharmacology 26:6, pages 513-519.
Crossref
Crossref
Leslie Briars & Timothy Todd. (2016) A Review of Pharmacological Management of Attention-Deficit/Hyperactivity Disorder. The Journal of Pediatric Pharmacology and Therapeutics 21:3, pages 192-206.
Crossref
Crossref
Henrik Berg Rasmussen, Ditte Bjerre, Kristian Linnet, Gesche Jürgens, Kim Dalhoff, Hreinn Stefansson, Thomas Hankemeier, Rima Kaddurah-Daouk, Olivier Taboureau, Søren Brunak, Tine Houmann, Pia Jeppesen, Anne Katrine Pagsberg, Kerstin Plessen, Jørgen Dyrborg, Peter Riis Hansen, Poul Erik Hansen, Tim Hughes & Thomas Werge. (2015) Individualization of treatments with drugs metabolized by CES1: combining genetics and metabolomics. Pharmacogenomics 16:6, pages 649-665.
Crossref
Crossref
Frances Prevatt, Vincent Dehili, Nicki Taylor & Diana Marshall. (2012) Anxiety in College Students With ADHD. Journal of Attention Disorders 19:3, pages 222-230.
Crossref
Crossref
Emili Banerjee & Krishnadas Nandagopal. (2015) Does serotonin deficit mediate susceptibility to ADHD?. Neurochemistry International 82, pages 52-68.
Crossref
Crossref
Mathieu Bilodeau, Tarek Simon, Miriam H. Beauchamp, Paul Lespérance, Simon Dubreucq, Jean-Pierre Dorée & Smadar Valérie Tourjman. (2012) Duloxetine in Adults With ADHD. Journal of Attention Disorders 18:2, pages 169-175.
Crossref
Crossref
Dongyi (Tony) Du, Esther H. Zhou, John Goldsmith, Clark Nardinelli & Tarek A. Hammad. (2012) Atomoxetine Use During a Period of FDA Actions. Medical Care 50:11, pages 987-992.
Crossref
Crossref
Nikki Ivanchak, Kristen Fletcher & Gregory A. Jicha. (2012) Attention-Deficit/Hyperactivity Disorder in Older Adults: Prevalence and Possible Connections to Mild Cognitive Impairment. Current Psychiatry Reports 14:5, pages 552-560.
Crossref
Crossref
Morteza Jafarinia, Mohammad‐Reza Mohammadi, Amirhossein Modabbernia, Mandana Ashrafi, Danial Khajavi, Mina Tabrizi, Noorollah Yadegari & Shahin Akhondzadeh. (2012) Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study. Human Psychopharmacology: Clinical and Experimental 27:4, pages 411-418.
Crossref
Crossref
Wen-Jiun ChouShin-Jaw ChenYing-Sheue ChenHsin-Yi LiangChih-Chien LinChing-Shu TangYu-Shu HuangChin-Bin YehMiao-Chun ChouDai-Yueh LinPo-Hsun HouYu-Yu WuHung-Jen LiuYa-Fen HuangKai-Ling HwangChin-Hong ChanChia-Ho PanHsueh-Ling ChangChi-Fen HuangJu-Wei Hsu. (2012) Remission in Children and Adolescents Diagnosed with Attention-Deficit/Hyperactivity Disorder via an Effective and Tolerable Titration Scheme for Osmotic Release Oral System Methylphenidate. Journal of Child and Adolescent Psychopharmacology 22:3, pages 215-225.
Crossref
Crossref
Seyed-Hesameddin Abbasi, Shahram Heidari, Mohammad-Reza Mohammadi, Mina Tabrizi, Ali Ghaleiha & Shahin Akhondzadeh. (2011) Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial. Child Psychiatry & Human Development 42:3, pages 367-375.
Crossref
Crossref
H. M. Conklin, S. Helton, J. Ashford, R. K. Mulhern, W. E. Reddick, R. Brown, M. Bonner, B. W. Jasper, S. Wu, X. Xiong & R. B. Khan. (2009) Predicting Methylphenidate Response in Long-Term Survivors of Childhood Cancer: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial. Journal of Pediatric Psychology 35:2, pages 144-155.
Crossref
Crossref
Bahman Salehi, Reza Imani, Mohammad Reza Mohammadi, Jalil Fallah, Mohammad Mohammadi, Ahmad Ghanizadeh, Ali Akbar Tasviechi, Ardalan Vossoughi, Shams-Ali Rezazadeh & Shahin Akhondzadeh. (2010) Ginkgo biloba for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 34:1, pages 76-80.
Crossref
Crossref
Mohammad-Reza Mohammadi, Mohammad-Reza Kazemi, Ebtehal Zia, Shams-Ali Rezazadeh, Mina Tabrizi & Shahin Akhondzadeh. (2010) Amantadine versus methylphenidate in children and adolescents with attention deficit/hyperactivity disorder: a randomized, double-blind trial. Human Psychopharmacology: Clinical and Experimental, pages n/a-n/a.
Crossref
Crossref
Ali-Reza Zarinara, Mohammad-Reza Mohammadi, Nazanin Hazrati, Mina Tabrizi, Shams-Ali Rezazadeh, Farzin Rezaie & Shahin Akhondzadeh. (2010) Venlafaxine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Human Psychopharmacology: Clinical and Experimental, pages n/a-n/a.
Crossref
Crossref
Sharon B. Wigal. (2009) Efficacy and Safety Limitations of Attention-Deficit Hyperactivity Disorder Pharmacotherapy in Children and Adults. CNS Drugs 23:Supplement 1, pages 21-31.
Crossref
Crossref
Manijeh Kahbazi, Aboulfazl Ghoreishi, Fatemeh Rahiminejad, Mohammad-Reza Mohammadi, Abbas Kamalipour & Shahin Akhondzadeh. (2009) A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. Psychiatry Research 168:3, pages 234-237.
Crossref
Crossref
Heather M. Conklin, Joanne Lawford, Bruce W. Jasper, E. Brannon Morris, Scott C. Howard, Susan W. Ogg, Shengjie Wu, Xiaoping Xiong & Raja B. Khan. (2009) Side Effects of Methylphenidate in Childhood Cancer Survivors: A Randomized Placebo-Controlled Trial. Pediatrics 124:1, pages 226-233.
Crossref
Crossref
Shahrokh Amiri, Mohammad-Reza Mohammadi, Mohammad Mohammadi, Gholam-Hossein Nouroozinejad, Manijeh Kahbazi & Shahin Akhondzadeh. (2008) Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: A double blind, randomized clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32:1, pages 145-149.
Crossref
Crossref